Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters










Database
Language
Publication year range
1.
Arch Virol ; 150(5): 967-79, 2005 May.
Article in English | MEDLINE | ID: mdl-15662485

ABSTRACT

Vaccination of the susceptible livestock with potent, safe and cost effective vaccine is the primary requirement to control foot-and-mouth disease (FMD) in an endemic country. In this study, an alternative approach was used in which structural protein genes of all the four serotypes of FMDV (O, Asia 1, A22 and C) were expressed separately in methylotrophic yeast Pichia pastoris. The recombinant polyproteins (P1) were characterized by SDS-PAGE and in Western Blot analysis. Partially purified protein was used for immunization in guinea pigs with different adjuvant formulations and immune response studied. Ninety micrograms of the recombinant protein per monovalent dose was used for immunization. A single injection of a monovalent or polyvalent vaccine was given to guinea pigs with various adjuvant combinations viz., Monovalent recombinant protein either adjuvanted with Montanide-ISA50V or Indigenous oil, Monovalent recombinant protein mixed with 1/10th dose of inactivated oil-adjuvanted virus vaccine and Polyvalent recombinant protein with Montanide ISA50V. FMDV specific humoral immune response was observed at about 28th day post vaccination. The immune response as assessed by indirect ELISA and Serum neutralization test titres was found to be 320-640 and 16-32, respectively. When challenged with virulent homologous type 'O' virus, the guinea pigs showed protective C index of 2.01,1.81, 2.56 and 2.48, respectively, with above said adjuvant combinations. The study has shown that yeast-expressed FMDV P1 polyprotein in a single dose could elicit a protective immune response in guinea pigs, and this could be a possible future vaccine candidate in homologous host.


Subject(s)
Antibodies, Viral/blood , Foot-and-Mouth Disease Virus/immunology , Foot-and-Mouth Disease/prevention & control , Polyproteins/immunology , Vaccines, Synthetic/administration & dosage , Viral Proteins/immunology , Viral Vaccines/administration & dosage , Animals , Female , Foot-and-Mouth Disease Virus/pathogenicity , Guinea Pigs , Male , Neutralization Tests , Pichia/genetics , Pichia/metabolism , Polyproteins/genetics , Polyproteins/metabolism , Vaccination , Vaccines, Synthetic/genetics , Vaccines, Synthetic/immunology , Viral Proteins/genetics , Viral Proteins/metabolism , Viral Vaccines/genetics , Viral Vaccines/immunology
2.
Virus Res ; 92(2): 141-9, 2003 Apr.
Article in English | MEDLINE | ID: mdl-12686422

ABSTRACT

Foot and mouth disease virus (FMDV) is the aetiological agent of a highly contagious vesicular disease of cloven-hooved animals. The gene coding for the capsid polyprotein (P1) of FMDV from serotype 'O' vaccine strain (O75Madras) was cloned and expressed in yeast Pichia pastoris. The expressed P1 protein was characterised by sodium dodecyl sulphate polyacrylamide gel electrophoresis (SDS-PAGE) and Western Blot analysis. Immunisation of Guinea pigs with recombinant P1 induced FMDV type O specific immune response. The humoral response to vaccine was measured by indirect ELISA and a serum neutralisation test (SNT). The Guinea pig sera showed high titres both in ELISA and SNT. Upon challenge with virulent Guinea pig adapted homologous type 'O' virus, the animals showed a protective index of 2.52. This study shows that the yeast expressed FMDV P1 could be a safe vaccine in non-endemic countries and a cost-effective vaccine in endemic countries. This is the first report on the production of FMDV structural proteins in yeast and their application as a vaccine.


Subject(s)
Antibodies, Viral/blood , Capsid Proteins/immunology , Foot-and-Mouth Disease/prevention & control , Pichia/immunology , Protein Precursors/immunology , Viral Vaccines/immunology , Animals , Capsid/metabolism , Capsid Proteins/genetics , Foot-and-Mouth Disease/immunology , Foot-and-Mouth Disease Virus/classification , Foot-and-Mouth Disease Virus/immunology , Guinea Pigs , Immunization , Neutralization Tests , Pichia/genetics , Protein Precursors/genetics , Vaccines, Synthetic/administration & dosage , Vaccines, Synthetic/immunology , Viral Vaccines/administration & dosage , Viral Vaccines/genetics
3.
Biochem Mol Biol Int ; 46(6): 1093-100, 1998 Dec.
Article in English | MEDLINE | ID: mdl-9891841

ABSTRACT

A cDNA library of Rinderpest vaccine virus was prepared in Zap Express vector (Stratagene). The Rinderpest 'N' gene specific clones were selected, characterized and thereafter expressed in E. coli XLOLR strain. The expressed protein was found to be immunogenic in western blot with hyperimmune sera. It reacted with rinderpest and 'N' protein specific monoclonal antibodies in Enzyme Linked Immunosorbent Assay (ELISA). Prokaryotically expressed 'N' protein also gave precipitin band in counter immunoelectrophoresis test (CIE). The expression of N protein was sufficient for its utility as positive antigen in CIE and ELISA used for rinderpest diagnosis.


Subject(s)
Antigens, Viral/immunology , Nucleocapsid Proteins/immunology , Rinderpest virus/immunology , Viral Vaccines , Animals , Antibodies, Monoclonal , Antigens, Viral/analysis , Chlorocebus aethiops , DNA, Complementary , Enzyme-Linked Immunosorbent Assay/methods , Gene Library , Nucleocapsid Proteins/analysis , Nucleocapsid Proteins/genetics , Polymerase Chain Reaction , Recombinant Proteins/analysis , Recombinant Proteins/immunology , Rinderpest virus/genetics , Transfection , Vero Cells
SELECTION OF CITATIONS
SEARCH DETAIL
...